Cite
HARVARD Citation
Qin, Y. et al. (n.d.). PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. Leukemia & lymphoma. 54 (7), pp. 1442-1449. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Qin, Y. et al. (n.d.). PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes. Leukemia & lymphoma. 54 (7), pp. 1442-1449. [Online].